THY1 and acute myeloid leukemia: The addition of AICAr and brequinar at doses that efficiently induce differentiation of AML cells had no effect on the expression of stromal cell markers, except that AICAr significantly increased the expression of CD73 and CD90 when applied at a higher dose of 0.5 mM (Fig. 4F).